1.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL01, NCT00198991
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 1 to 17
Sponsor: Other
Protocol IDs: CDR0000686545, GPOH-COALL-08-09, EUDRACT-2009-012758-18, EU-21076, NCT01228331
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: AMLCG 99, BMBF 01 GI 02070, NCT00266136
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to 18
Sponsor: Other
Protocol IDs: CDR0000528029, ALL-BFM-2000, EU-20682, NCT00430118
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: NCI, Other
Protocol IDs: TOTXVI, 5R01CA140729, 5F32CA141762, NCT00549848
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: CDR0000613220, MOTOL-ALL-IC-BFM-2002, EU-20871, ALL-IC-BFM-2002, NCT00764907
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to 18
Sponsor: Other
Protocol IDs: CCLG-ALLR3, CCLG-ALLR3, ISCRTN-45724312, EUDRACT-2004-000052-16, EU-20938, NCT00967057
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 18
Sponsor: Other
Protocol IDs: AIEOP-BFM ALL 2009, NCT01117441
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to < 10
Sponsor: NCI
Protocol IDs: COG-AALL0932, AALL0932, NCT01190930
|
|
10.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 30
Sponsor: NCI
Protocol IDs: COG-AALL1131, AALL1131, NCT01406756
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 16 to 39
Sponsor: NCI
Protocol IDs: CALGB-10403, CALGB 10403, ECOG C10403, SWOG C10403, NCT00558519
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 12 to 40
Sponsor: Other
Protocol IDs: 2006-0375, NCT00866749
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: NHL16, NCT01451515
|
|
14.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 1 to 18
Sponsor: Other
Protocol IDs: GER-COALL-07-03, EU-205104, NCT00343369
|
|
15.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 365 days and under
Sponsor: Other
Protocol IDs: CDR0000570260, DCOG-INTERFANT-06, EUDRACT-2005-004599-19, CCLG-LK-2006-10, NCT00550992
|
|
16.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: Child
Sponsor: Other
Protocol IDs: POWH-CRE-2008.077-T, CRE-2008.077-T, NCT00707083
|
|
17.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: Under 35
Sponsor: Other
Protocol IDs: LAL1308, GIMEMA-LAL1308, EU-21042, NCT01156883
|
Mobile | Español
